Search Results - "Liang, Riying"
-
1
Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis
Published in Endocrine Connections (01-10-2020)“…Background: Obesity is associated with the development and progression of chronic kidney disease. Emerging evidence suggests that glucagon-like peptide-1…”
Get full text
Journal Article -
2
520-P: Exenatide Ameliorates Diabetic Kidney Disease by Inhibiting Apoptosis via SIRT1/TXNIP Signal Pathway
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Recent studies have indicated apoptosis to be a major contributor to the progression of Diabetic Kidney Disease. GLP-1 agonist such as Exenatide, which…”
Get full text
Journal Article -
3
1138-P: Empagliflozin Ameliorates Kidney Injury in Diabetic Nephropathy via SIRT1 and TXNIP
Published in Diabetes (New York, N.Y.) (01-06-2020)“…SGLT2 inhibitor empagliflozin can slower the decline of eGFR and reduce the occurrence rate of end-stage kidney disease according to EMPA-REG OUTCOME Clinical…”
Get full text
Journal Article -
4
2032-P: The Effects of Liraglutide on Ameliorating Diabetic Kidney Disease Is via SIRT1/TXNIP Pathway
Published in Diabetes (New York, N.Y.) (01-06-2019)“…GLP-1 receptor agonist is one of the most effective drugs to treat type 2 diabetes. LEADER Clinical Trials revealed that liraglutide exerted its renoprotective…”
Get full text
Journal Article